» Articles » PMID: 8415403

Stereoselective Interactions of Organic Cations with the Organic Cation Transporter in OK Cells

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1993 Aug 1
PMID 8415403
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have suggested that certain organic cations, such as pindolol and the diastereomers, quinine and quinidine, may be stereoselectively secreted by the kidney in humans. The goal of this study was to determine if the enantiomers of pindolol, verapamil, and disopyramide and the diastereomers, quinine and quinidine, interact stereoselectively with the organic cation transporter in the brush border membrane of the opossum kidney cell line. All organic cations tested inhibited the uptake of tetraethylammonium (TEA). The IC50 values (mean +/- SD) were as follows: quinine (17 +/- 2 microM). quinidine (51 +/- 13 microM), S-(-)-pindolol (23 +/- 4 microM), R-(+)-pindolol (30 +/- 4 microM), S-(-)-verapamil (0.4 +/- 0.04 microM), R-(+)-verapamil (7 +/- 2 microM), R-(-)-disopyramide (27 +/- 4 microM), and S-(+)-disopyramide (66 +/- 12 microM). Each individual organic cation pair showed significant stereoselective differences in their IC50 values, with quinine, S-(-)-pindolol, S-(-)-verapamil, and R-(-)-disopyramide being the more potent species. Both enantiomers of pindolol, quinine, and quinidine appear to exhibit simple competitive inhibition of TEA uptake based upon a derived slope similar to 1.0, using a sigmoidal inhibition model. The enantiomers of verapamil and disopyramide exhibited a slope of much less than 1.0, suggesting a more complex interaction of these organic cations with the TEA transporter. Our results suggest that organic cations stereoselectively interact with the organic cation transporter in the brush border membrane of OK cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters.

Gebauer L, Jensen O, Rafehi M, Brockmoller J Mol Pharm. 2023; 20(12):6289-6300.

PMID: 37962560 PMC: 10698726. DOI: 10.1021/acs.molpharmaceut.3c00691.


Renal Drug Transporters and Drug Interactions.

Ivanyuk A, Livio F, Biollaz J, Buclin T Clin Pharmacokinet. 2017; 56(8):825-892.

PMID: 28210973 DOI: 10.1007/s40262-017-0506-8.


The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen.

Weitschies W, Bernsdorf A, Giessmann T, Zschiesche M, Modess C, Hartmann V Pharm Res. 2005; 22(5):728-35.

PMID: 15906167 DOI: 10.1007/s11095-005-2588-5.


Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.

Hanada K, Odaka K, Kudo A, Ogata H Pharm Res. 1999; 16(10):1589-95.

PMID: 10554102 DOI: 10.1023/a:1018912806355.

References
1.
Ott R, Hui A, Yuan G, Giacomini K . Organic cation transport in human renal brush-border membrane vesicles. Am J Physiol. 1991; 261(3 Pt 2):F443-51. DOI: 10.1152/ajprenal.1991.261.3.F443. View

2.
Muirhead M, Bochner F, Somogyi A . Pharmacokinetic drug interactions between triamterene and ranitidine in humans: alterations in renal and hepatic clearances and gastrointestinal absorption. J Pharmacol Exp Ther. 1988; 244(2):734-9. View

3.
Holohan P, Ross C . Mechanisms of organic cation transport in kidney plasma membrane vesicles: 2. delta pH studies. J Pharmacol Exp Ther. 1981; 216(2):294-8. View

4.
Wright S, Wunz T . Transport of tetraethylammonium by rabbit renal brush-border and basolateral membrane vesicles. Am J Physiol. 1987; 253(5 Pt 2):F1040-50. DOI: 10.1152/ajprenal.1987.253.5.F1040. View

5.
Delean A, Munson P, Rodbard D . Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978; 235(2):E97-102. DOI: 10.1152/ajpendo.1978.235.2.E97. View